You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Ladakamycin

Showing 51 - 75 of 90
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Leukemia Trial in United States (Azacitidine (AZA) Days 1 - 3, Decitabine (DAC), Best Supportive Care (BSC))

Active, not recruiting
  • Leukemia
  • Azacitidine (AZA) Days 1 - 3
  • +3 more
  • Tampa, Florida
  • +5 more
Jul 21, 2020

Acute Myeloid Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Secondary Acute Myeloid Leukemia

Recruiting
  • Acute Myeloid Leukemia
  • +3 more
  • Greenwich, Connecticut
  • +27 more
Dec 30, 2022

Acute Myeloid Leukemia, Adult Acute Megakaryoblastic Leukemia, Adult Acute Monoblastic Leukemia Trial in United States

Completed
Has Results
  • Acute Myeloid Leukemia
  • +19 more
  • Allogeneic Hematopoietic Stem Cell Transplantation
  • +8 more
  • Lewes, Delaware
  • +16 more
Aug 3, 2022

Hematopoietic and Lymphoid Cell Tumor, Recurrent Acute Lymphoblastic Leukemia, Recurrent Acute Myeloid Leukemia Trial in Houston

Active, not recruiting
  • Hematopoietic and Lymphoid Cell Neoplasm
  • +8 more
  • Houston, Texas
    M D Anderson Cancer Center
Oct 6, 2022

Leukemia Trial in Houston (Lirilumab, Nivolumab, Azacitidine)

Terminated
Has Results
  • Leukemia
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Jan 6, 2020

Acute Myeloid Leukemia, Myelodysplastic Syndrome, Myelodysplastic/Myeloproliferative Tumor Trial in Houston (Azacitidine, BRD4

Recruiting
  • Acute Myeloid Leukemia
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
Mar 19, 2020

Recurrent Non-Small Cell Lung Carcinoma, Stage IV NSCLC Trial in Bronx (Azacitidine, Laboratory Biomarker Analysis,

Completed
  • Recurrent Non-Small Cell Lung Carcinoma
  • Stage IV Non-Small Cell Lung Cancer
  • Bronx, New York
    Albert Einstein College of Medicine
Feb 5, 2020

Leukemia, AML, MDS Trial in Houston (Azacitidine)

Completed
Has Results
  • Leukemia
  • +2 more
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Jan 6, 2020

Advanced Cancers, Lymphoma Trial in Houston (Azacitidine, Vorinostat, Gemcitabine)

Completed
Has Results
  • Advanced Cancers
  • Lymphoma
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Jan 14, 2020

Leukemia Trial in Houston (Azacytidine, Sorafenib)

Completed
Has Results
  • Leukemia
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Jan 6, 2020

MDS, Acute Myeloid Leukemia, AML Trial in Saint Louis (CX-01, Azacitidine, Bone marrow biopsy)

Completed
  • Myelodysplastic Syndromes
  • +3 more
  • Saint Louis, Missouri
    Washington University School of Medicine
Dec 4, 2019

Leukemia, Myeloid, Acute, MDS, Precursor Cell Lymphoblastic Leukemia-Lymphoma Trial in Saint Louis (Azacitidine)

Terminated
Has Results
  • Leukemia, Myeloid, Acute
  • +2 more
  • Saint Louis, Missouri
    Washington University School of Medicine
Sep 27, 2019

Acute Myeloid Leukemia, High Risk Myelodysplastic Syndrome Trial in Houston (Azacitidine, Cytarabine, Tosedostat)

Terminated
  • Acute Myeloid Leukemia
  • High Risk Myelodysplastic Syndrome
  • Houston, Texas
    M D Anderson Cancer Center
Apr 9, 2020

Recurrent Lung Non-Small Cell Carcinoma, Stage IV Lung Non-Small Cell Cancer AJCC v7 Trial in Columbus (Azacitidine, Diagnostic

Completed
Has Results
  • Recurrent Lung Non-Small Cell Carcinoma
  • Stage IV Lung Non-Small Cell Cancer AJCC v7
  • Columbus, Ohio
    Ohio State University Comprehensive Cancer Center
Sep 16, 2019

Acute Biphenotypic Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Recurrent Acute Myeloid

Terminated
Has Results
  • Acute Biphenotypic Leukemia
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
Sep 5, 2019

Acute Myeloid Leukemia, Chronic Myelomonocytic Leukemia, de Novo Myelodysplastic Syndrome Trial in Baltimore, New York

Completed
  • Acute Myeloid Leukemia
  • +7 more
  • Baltimore, Maryland
  • +2 more
Oct 17, 2019

Leukemia Trial in Houston (Pacritinib, 5-azacitidine, Decitabine)

Terminated
Has Results
  • Leukemia
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Sep 18, 2018

Leukemia Trial in Houston (5-azacytidine, PKC412)

Completed
Has Results
  • Leukemia
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Sep 18, 2018

Acute Myeloid Leukemia, Adult Acute Megakaryoblastic Leukemia, Adult Acute Monoblastic Leukemia Trial in United States

Active, not recruiting
Has Results
  • Acute Myeloid Leukemia
  • +13 more
  • Burbank, California
  • +176 more
Mar 25, 2022

Stage IA Non-Small Cell Lung Carcinoma, Stage IB Non-Small Cell Lung Carcinoma Trial in United States (Azacitidine, Entinostat,

Terminated
Has Results
  • Stage IA Non-Small Cell Lung Carcinoma
  • Stage IB Non-Small Cell Lung Carcinoma
  • Los Angeles, California
  • +8 more
Jan 14, 2019

Chronic Myelomonocytic Leukemia, Chronic Myelomonocytic Leukemia-1, Chronic Myelomonocytic Leukemia-2 Trial in Canada, United

Active, not recruiting
Has Results
  • Chronic Myelomonocytic Leukemia
  • +6 more
  • Birmingham, Alabama
  • +297 more
Jan 28, 2023

Recurrent Non-Small Cell Lung Carcinoma, Stage IIIA NSCLC, Stage IIIB NSCLC Trial in United States (Azacitidine, Docetaxel,

Terminated
Has Results
  • Recurrent Non-Small Cell Lung Carcinoma
  • +3 more
  • Los Angeles, California
  • +4 more
Jun 29, 2018

Acute Leukemia of Ambiguous Lineage, B Acute Lymphoblastic Leukemia, Mixed Phenotype Acute Leukemia Trial in Worldwide

Active, not recruiting
Has Results
  • Acute Leukemia of Ambiguous Lineage
  • +2 more
  • Birmingham, Alabama
  • +173 more
Nov 16, 2021

Acute Myeloid Leukemia, Myelodysplastic Syndrome, Myelodysplastic Syndrome With Excess Blasts-2 Trial in United States (drug,

Active, not recruiting
  • Acute Myeloid Leukemia
  • +2 more
  • Anchorage, Alaska
  • +506 more
Jan 28, 2023

Leukemia, FLT3-Mutated Acute Myeloid Leukemia, FLT3-Mutated High-Risk Myelodysplastic Syndrome Trial (Ponatinib, 5-azacytidine,

Withdrawn
  • Leukemia
  • +2 more
  • (no location specified)
Jun 1, 2017